Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program

Sponsor
National Center for Research Resources (NCRR) (NIH)
Overall Status
Completed
CT.gov ID
NCT00035217
Collaborator
Urological Research Foundation (Other)
1

Study Details

Study Description

Brief Summary

There is controversy concerning the preferred treatment for men with localized prostate cancer with regard to the relative effectiveness of different treatments in controlling the cancer and how different treatments affect the patient's quality of life. The purpose of this research is to describe the disease course of prostate cancer and to determine the effectiveness, potential complications, and quality of life after different treatments in men with prostate cancer detected via screening with prostate-specific antigen (PSA) and/or digital rectal examination

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Observational Model:
    Defined Population
    Time Perspective:
    Other
    Official Title:
    Follow-Up Study for Men Diagnoses With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      40 Years and Older
      Sexes Eligible for Study:
      Male
      Accepts Healthy Volunteers:
      No

      Men with prostate cancer diagnosed through the PSA screening study

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Washington University School of Medicine St. Louis Missouri United States 63110

      Sponsors and Collaborators

      • National Center for Research Resources (NCRR)
      • Urological Research Foundation

      Investigators

      None specified.

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00035217
      Other Study ID Numbers:
      • NCRR-M01RR00036-0838
      First Posted:
      May 3, 2002
      Last Update Posted:
      Jun 24, 2005
      Last Verified:
      Dec 1, 2003
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Jun 24, 2005